Nutrition Lecture (9/22)

Carbohydrates, Lactose Metabolism, and Lactose Intolerance

• Dietary Sources and Monosaccharide Structure:

  • Lactose is a disaccharide carbohydrate found predominantly in dairy products, such as milk.

  • Lactose cannot be absorbed directly by the human gastrointestinal tract; it must first be enzymatically hydrolyzed into its constituent monosaccharides: glucose and galactose.

  • The three monosaccharides that the human body can readily digest and absorb are glucose, fructose, and galactose.

  • The specific enzyme responsible for breaking down lactose into glucose and galactose is lactase (the suffix -ase designates an enzyme).

• Normal Digestion and Absorption Pathway:

  • Digestion of lactose occurs within the lumen of the small intestine via the action of lactase.

  • Once broken down into glucose and galactose, these monosaccharides are absorbed across the intestinal epithelium directly into the bloodstream.

  • From the bloodstream, the absorbed sugars are transported directly to the liver for metabolic processing.

  • Note: Dietary fats follow a distinct absorption path, entering the lymphatic system via lymph nodes before entering systemic circulation, whereas carbohydrates enter the hepatic portal system directly.

• Pathophysiology of Lactose Intolerance:

  • Lactose intolerance results from a deficiency or complete absence of the intestinal enzyme lactase.

  • Without lactase, dietary lactose remains undigested and unabsorbed as it travels through the digestive tract.

  • The unabsorbed lactose accumulates in the lumen of the colon, where it interacts with resident gastrointestinal flora (gut microbiota) and undergoes microbial fermentation.

• Clinical Manifestations of Intolerance:

  • Abdominal cramping and pain

  • Nausea

  • Watery diarrhea

  • Gastrointestinal rumbling (borborygmi) and severe bloating

  • Symptoms persist until all undigested lactose is evacuated from the body.

• Treatment and Management Strategies:

  • Exogenous Enzyme Replacement: Administration of oral lactase enzyme supplements (e.g., Lactaid) prior to consuming dairy products.

    • Exogenous lactase cleaves lactose in the gut into glucose and galactose, permitting normal absorption.

    • Exact dosing is critical: under-dosing exogenous lactase relative to the volume of lactose consumed (such as consuming dairy-based soup with inadequate lactase supplementation) leads to incomplete breakdown and severe nocturnal gastrointestinal distress.

  • Dietary Modification and Dairy Restriction:

    • Patients are advised to limit overall dairy intake, as enzyme replacement may not process large boluses of lactose.

    • Utilization of non-dairy alternatives: coconut milk, cashew milk, almond milk, oat milk, or commercial Lactaid milk (which contains added exogenous lactase).

    • Consumption of naturally low-lactose dairy: Aged cheeses (e.g., Swiss cheese, cheddar cheese, Parmesan cheese) contain significantly lower amounts of lactose due to the aging process and are often tolerated well (Kaplan clinical recommendation).

• Complications of Continued Ingestion:

  • Repeated ingestion of lactose in intolerant individuals causes chronic intestinal irritation and damage to the intestinal villi.

  • Severe damage to the villi flattens the mucosal surface area, ultimately leading to generalized nutrient malabsorption syndrome.

Intestinal Villi Regeneration and Galactosemia

• Recovery of Intestinal Villi:

  • Regeneration of damaged intestinal villi depends on individual physiological capacity, the etiology of the damage (genetic versus acquired), and the extent of tissue atrophy.

  • If villi damage is mild to moderate, tissue can self-heal over time, provided there is strict, complete cessation of dietary lactose exposure for a prolonged period.

  • Repeated exposure to lactose does not "train" or adapt the gut to produce lactase; individuals lacking the enzyme cannot stimulate endogenous production through exposure.

• Galactosemia Etiology and Pathophysiology:

  • Galactosemia is a rare, autosomal recessive genetic metabolic disorder of carbohydrate metabolism (textbook page 362).

  • Normal Hepatic Conversion: In normal physiology, digested monosaccharides (glucose, fructose, and galactose) enter the liver. The liver utilizes specific enzymes to convert galactose and fructose into glucose, as glucose is the essential substrate utilized for cellular energy and central nervous system function (galactose cannot cross the blood-brain barrier).

  • Metabolic Defect: Patients with galactosemia possess normal gastrointestinal lactase and successfully break down lactose into glucose and galactose; however, they completely lack the essential liver enzymes needed to convert galactose into glucose.

  • Distinction from Lactose Intolerance:

    • Lactose intolerance is a gastrointestinal lumen enzyme deficiency that can be treated with oral enzyme ingestion.

    • Galactosemia is an intracellular liver enzyme defect occurring post-absorption; oral enzyme administration is completely ineffective because exogenous enzymes cannot reach or function inside hepatic tissue.

• Systemic Pathological Accumulation:

  • Because galactose cannot be converted into glucose, toxic concentrations of galactose and its metabolites accumulate in the bloodstream and deposit into vital organ tissues.

  • Hepatic and Splenic Pathology:

    • Hepatomegaly (pathological enlargement of the liver; root hepat = liver, suffix -megaly = enlargement).

    • Splenomegaly (pathological enlargement of the spleen).

    • Jaundice (icterus; yellow discoloration of the skin and sclera due to bilirubin accumulation secondary to hepatic dysfunction).

    • Cirrhosis (chronic hepatic inflammation and severe scarring).

    • Progressive, fatal liver failure if left untreated.

  • Ocular Pathology: Deposition of galactose metabolites in the ocular lens results in cataract formation.

  • Neurological Pathology: Accumulation within central nervous system tissue leads to brain damage and severe intellectual disability (mental retardation).

  • Infant Clinical Indicators: Initiation of milk feeding in an affected infant triggers severe nausea, vomiting, and diarrhea, serving as a key diagnostic clinical sign.

• Clinical Management of Galactosemia:

  • Requires permanent, strict elimination of all dietary galactose and lactose ("zero intake").

  • Prohibited Foods: Absolute prohibition of all dairy products, milk, butter, ice cream, cheese, and human breast milk (breast milk contains high concentrations of lactose, which breaks down into glucose and galactose).

  • Infant Feeding Guidelines: Affected infants must be immediately transitioned to a soy-based infant formula.

  • Alternative Infant Formula: If the infant exhibits a concurrent soy allergy, a specialized hypoallergenic infant formula must be utilized.

Diabetes Mellitus and Blood Glucose Regulation

• Etiology and Classification:

  • Type 1 Diabetes Mellitus: A genetic/autoimmune condition characterized by immune-mediated destruction of pancreatic beta cells, resulting in absolute insulin deficiency.

  • Type 2 Diabetes Mellitus: An acquired metabolic disorder characterized by progressive peripheral insulin resistance paired with relative insulin secretion defects.

• Physiology of Insulin:

  • Insulin functions as the cellular "key" required to facilitate the uptake of glucose from the vascular space into body cells.

  • In the absence of functional insulin action:

    1. Cells are starved of metabolic fuel.

    2. Unabsorbed glucose accumulates within the systemic circulation, causing marked hyperglycemia.

• Glycemic Targets and Clinical Laboratory Metrics:

  • Normal Fasting Blood Glucose: $70\text{ to }110\,mg/dL$.

  • Hemoglobin A1c (HbA1c):

    • Glycated hemoglobin reflects average systemic blood glucose control over the preceding life cycle of a red blood cell.

    • Red blood cell lifespan: approximately $120\text{ days}$ (or $3\text{ months}$).

    • Normal non-diabetic HbA1c range: $4.5\%\text{ to }6.5\%$.

    • Diabetic therapeutic target HbA1c: Less than $7.0\%$.

    • Clinical diagnostic example: An initial diagnostic HbA1c of $12.4\%$ correlates with sustained chronic blood glucose levels in the high $300\text{s}$ to low $400\text{s}\,mg/dL$ range; therapeutic interventions aim to lower this value below $7.0\%$ (e.g., reduction down to $8.1\%$).

• Diabetic Dietary Management:

  • Caloric Guidelines: American Diabetes Association (ADA) guidelines establish an $1800\text{-calorie}$ daily meal plan template (adjusted down from the standard healthy adult baseline of $2000\text{ calories}$ based on clinical research).

  • Carbohydrate Selection: Emphasize complex carbohydrates paired with high dietary fiber content (e.g., non-starchy vegetables).

    • Dietary fiber cannot be digested or absorbed, yields $0\text{ calories}$, and does not raise blood glucose, making it an ideal substrate to promote satiety.

    • Eliminate simple starches and added sugars (standard diets limit added sugars to less than $50\,g/day$; diabetic diets require complete avoidance of added sugar).

    • Utilize non-nutritive sweeteners and sugar substitutes (e.g., Stevia, polyols/menthols).

• Carbohydrate Counting and Prandial Insulin Dosing:

  • Standard Carbohydrate Unit: $1\text{ carbohydrate serving} = 15\,g\text{ of total carbohydrates}$.

  • Calculation Formula:         $\text{Carbohydrate Servings} = \frac{\text{Total Carbohydrates } (g)}{15\,g}$

  • Calculation Examples:

    • For a food containing $30\,g$ total carbohydrates:             $\frac{30\,g}{15\,g} = 2\text{ carbohydrate servings}$

    • For a food containing $37.5\,g$ total carbohydrates:             $\frac{37.5\,g}{15\,g} = 2.5\text{ carbohydrate servings}$

  • Clinical Application: In hospital settings, orders specify precise carbohydrate limits per meal (typically around $60\,g$ per meal, equal to $4\text{ carb servings}$). Rapid-acting prandial insulin is administered based on carb intake (e.g., $1\text{ unit of insulin}$ per $1\text{ carbohydrate serving}$ consumed).

Overview and Physiological Functions of Dietary Fats

• Metabolic Role and Energy Yield:

  • Fats (lipids) represent the human body's secondary primary energy substrate following carbohydrates.

  • Caloric Density: Dietary fat yields $9\text{ kilocalories per gram}$ ($9\,kcal/g$), compared to $4\,kcal/g$ provided by carbohydrates and proteins.

  • Adipose Storage: Excess caloric consumption from fats is stored in subcutaneous and visceral adipose tissue (textbook page 52).

• Fat Catabolism and Ketosis:

  • When the body rapidly catabolizes fat for fuel in the absence of carbohydrate substrates, ketone bodies are released into the bloodstream.

  • Ketone bodies are highly acidic; excessive systemic concentrations cause severe metabolic acidosis known as ketoacidosis.

  • Individuals adhering to strict ketogenic diets must monitor urinary ketone levels to avoid ketoacidosis.

• Essential Physiological Functions:

  • Absorption of Fat-Soluble Vitamins: Lipids are strictly required for the dissolution and intestinal absorption of fat-soluble vitamins: Vitamin A, Vitamin D, Vitamin E, and Vitamin K ($\text{Vitamins A, D, E, K}$). Because chemical solvents must match to dissolve substances, total dietary fat restriction prevents fat-soluble vitamin absorption.

  • Nervous System Architecture: Lipids build cell membrane bilayers and construct the myelin sheath insulating neuronal axons, facilitating rapid nerve impulse propagation.

  • Reproductive Health and Endocrine Function: Lipids support steroid hormone synthesis and reproductive fertility.

  • Visceral Protection: Adipose tissue cushions internal organs against mechanical impact and traumatic shock.

  • Thermal Insulation: Subcutaneous adipose tissue provides thermal regulation to maintain core body temperature (analogous to blubber layers in Arctic wildlife).

  • Palatability and Satiety: Enhances food flavor and slows gastric emptying to prolong satiety.

Lipid Classification, Dietary Guidelines, and Cardiovascular Health

• Dietary Fat Requirements:

  • Recommended Daily Allowance: $20\%\text{ to }35\%$ of total daily caloric intake should derive from lipids.

  • Diagnostic Evaluation: Fasting lipid panel values must be routinely evaluated against clinical laboratory references.

  • Organ Substrate Preferences: Fatty acids serve as the preferred primary metabolic fuel for cardiac muscle (myocardium), whereas glucose is the primary fuel for the brain.

• Classifications of Dietary Fats:

  1. Unsaturated Fats (Monounsaturated & Polyunsaturated Fats):

     • Nutritional Status: Healthy / Beneficial Fats ("Green Light").

     • Physical State: Typically liquid at room temperature due to double bonds in their carbon chains.

     • Chemical Stability: Less chemically stable than saturated fats; shorter shelf-life and prone to oxidative rancidity over time.

     • Dietary Sources: Cold-water fish (mackerel, herring, trout, salmon, tuna), plant oils, olives, avocados (olives and avocados are the only two fruits categorized in this lipid class), nuts, and seeds (sunflower seeds, sesame seeds, macadamia nuts, cashews, pistachios).

     • Heavy Metal Warning: Deep-sea fish such as tuna contain elevated levels of mercury (textbook page 166, Figure 9.3). Excessive consumption of high-mercury fish can induce heavy metal poisoning and alopecia (hair loss).

     • Cardiovascular Benefits: Rich in Omega-3 fatty acids. Consuming cold-water fish at least $2\text{ times per week}$ significantly decreases cardiovascular disease (CVD) risk and prevents thrombus formation by reducing platelet aggregation (exerting an antiplatelet effect similar to low-dose aspirin).

     • The Mediterranean Diet: Recommended dietary pattern high in olive oil, fish, and plant foods, with complete avoidance of red meat. Proven to lower serum cholesterol, reduce systemic inflammation, and protect cardiovascular health.

  2. Saturated Fats:

     • Nutritional Status: Moderate / Restrict ("Yellow Light" / Caution).

     • Physical State: Solid at room temperature.

     • Dietary Sources: Animal sources (beef, pork, poultry/turkey in lower amounts, egg yolks, whole milk, butter, full-fat dairy) and specific tropical oils (coconut oil, palm oil).

     • Quantitative Daily Limit: Must be restricted to less than $10\%$ of total daily calories, or less than $22\,g\text{ per day}$ on a standard diet.

     • Pathological Effects: Excessive intake of saturated fats (including coconut and palm oils) elevates total serum cholesterol and Low-Density Lipoprotein (LDL, "bad" cholesterol) levels, significantly increasing the risk of obesity, cardiovascular disease, hypertension, and type 2 diabetes mellitus.

  3. Trans Fats:

     • Nutritional Status: Harmful Fats ("Red Light" / Completely Avoid).

     • Chemical Formation: Created artificially through industrial hydrogenation—adding hydrogen ions across double bonds of unsaturated vegetable oils.

     • Industrial Purpose: Hydrogenation converts liquid oils into solid fats (e.g., stick margarine, commercial shortening like Crisco), creating chemical stability with extremely long shelf-lives (e.g., remaining un-rancid after 8 years).

     • Dietary Sources: Processed shelf-stable foods, commercial baked goods (cookies, cheesecake), chips, and deep-fried fast foods.

     • Pathological Effects: Highly atherogenic; severely elevates LDL cholesterol, induces endothelial dysfunction, and promotes coronary artery disease.

  4. Cholesterol:

     • Endogenous Synthesis: The liver naturally synthesizes all necessary endogenously required cholesterol; dietary intake must be restricted to prevent hypercholesterolemia.